VistaGen Therapeutics, Inc.VTGNNASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank21
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
-63.08%
↓ 28% vs avg
Percentile
P21
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
-49.46%
Historical baseline
PeriodValue
2025-63.08%
202448.08%
2023-9.85%
2022-274.84%
202123.38%
2020-8.46%
2019-60.38%
2018-24.73%
2017-51.03%
2016-73.66%